1

Paul Armentano – Did the DEA Just Kick Open the Door for the Pharmaceuticalization of Pot?

While much ink has been spilled over the last few days regarding DEA’s refusa [3]l to recognize marijuana as a medicine and its unwillingness to reclassify it under federal law, far less attention has been paid to a separate decision by the agency to create, for the first time, a “clear legal pathway” for pharmaceutical companies to engage in cannabis-specific “drug product …